CSPIA
SRNE

Cary Street Partners Investment Advisory’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-750
Closed -$665 – 1740
2022
Q4 		$665 Buy
+750
New +$665 ﹤0.01% 1604